Copyright
©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7139-7149
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7139
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7139
ES-AN, n = 52 | ES-AN/Ada, n = 30 | |
Crohn’s disease:Ulcerative colitis | 31 (60):21 (40) | 19 (63):11 (37) |
Males:Females | 22 (42):30 (58) | 17 (57):13 (43) |
Age in years | 47.2 ± 14.2 | 46.2 ± 14.4 |
Disease duration of IBD in years | 11.3 ± 10.1 | 8.8 ± 7.9 |
Smokers:Ex-smokers | 9 (17):20 (38) | |
HLA-B27 positivity | 5 (10) | 4 (13) |
Prior surgical intervention for IBD | 13 (25) | 5 (17) |
Previous extra-intestinal disease | 6 (11) | 5 (17) |
Eritema nodosum | 2 | 1 |
Uveitis | 3 | 3 |
Pioderma gangrenosum | 1 | 1 |
Crohn’s disease activity by CDAI | ||
Inactive | 14 (45) | 7 (37) |
Moderate | 10 (32) | 8 (42) |
Moderate-to-Severe | 7 (23) | 4 (21) |
Ulcerative colitis activity by partial Mayo | ||
Mild | 18 (86) | 8 (73) |
Moderate | 3 (14) | 3 (27) |
Severe | 0 | 0 |
Current medication at baseline | ||
Non-steroids anti-inflammatory drugs | 3 | 0 |
Sulfasalazine | 3 | 2 |
Mesalazine | 25 | 12 |
Cyclosporine | 1 | 1 |
Azathioprine | 9 | 5 |
Oral steroids | 12 | 7 |
Topical steroids | 3 | 2 |
Metotrexate | 2 | 1 |
Infliximab | 6 | 4 |
Adalimumab | 2 | 0 |
Spondyloarthritis features | ||
Ankylosing spondylitis according to Modified New York Criteria | 16 (31) | 10 (33) |
Non-radiographic Axial-Spondyloarthritis by ASAS Criteria | 13 (25) | 10 (33) |
Peripheral- Spondyloarthritis | 23 (44) | 10 (33) |
Type of axial involvement | n = 29 | n = 20 |
Syndesmophytosis | 8 (28) | 6 (30) |
Bamboo spine | 2 (7) | 2 (10) |
Sacroiliitis by MRI and/or X-ray | 29 (100) | 20 (100) |
Type of articular involvement in Crohn’s disease | n = 31 | n = 19 |
Axial | 16 (52) | 11 (58) |
Axial and peripheral | 4 | 3 |
Peripheral only | 15 (48) | 8 (42) |
Enthesitis | 9 (29) | 5 (26) |
Type of articular involvement in ulcerative colitis | n = 21 | n = 11 |
Axial | 13 (62) | 9 (82) |
Axial and peripheral | 9 | 5 |
Peripheral only | 8 (38) | 2 (18) |
Enthesitis | 4 (19) | 2 (18) |
- Citation: Luchetti MM, Benfaremo D, Ciccia F, Bolognini L, Ciferri M, Farinelli A, Rossini M, Mosca P, Triolo G, Gabrielli A. Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study. World J Gastroenterol 2017; 23(39): 7139-7149
- URL: https://www.wjgnet.com/1007-9327/full/v23/i39/7139.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i39.7139